Company intelligence / Profile preview

Senseye

Austin, Texas, United Statessenseye.co ↗

Ownership: Private
Employees: ~50
Development stage: Preclinical

Overview

Senseye has developed an AI-powered diagnostic platform that objectively identifies PTSD and other mental health conditions in minutes using smartphone-based eye tracking and biometric data. The technology replaces subjective self-reports with rapid, science-backed digital biomarkers. Early results indicate high accuracy for PTSD detection; expansion to MDD/GAD underway.

Therapeutic areas: Psychiatry
Modalities: Device (Software as a Medical Device)Digital biomarker platform
Industry: Digital Health Medical Devices

Beyond the preview

Go deeper on Senseye.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Senseye.

Explore the full profile